Old Web
English
Sign In
Acemap
>
authorDetail
>
Eyal Mishani
Eyal Mishani
Hadassah Medical Center
Nuclear medicine
Medicine
Dosimetry
11C erlotinib
Tyrosine-kinase inhibitor
4
Papers
141
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Head- to head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as Reference-Standard.
2019
The Journal of Nuclear Medicine
Jonathan Kuten
Ibrahim Fahoum
Ziv Savin
Ofer Shamni
Gilad Gitstein
Dov Hershkovitz
Nicola J. Mabjeesh
Ofer Yossepowitch
Eyal Mishani
Einat Even-Sapir
Show All
Source
Cite
Save
Citations (53)
A multi species evaluation of the radiation dosimetry of [11C]erlotinib, the radiolabeled analog of a clinically utilized tyrosine kinase inhibitor
2017
Nuclear Medicine and Biology
J. Ryan Petrulli
Søren B. Hansen
Galith Abourbeh
Maqsood Yaqub
Idris Bahce
Daniel Holden
Yiyun Huang
Nabeel Nabulsi
Joseph N. Contessa
Eyal Mishani
Adriaan A. Lammertsma
Evan D. Morris
Show All
Source
Cite
Save
Citations (4)
A multi-species, multi-site study of the radiation dosimetry of [11C] erlotinib, a radiolabeled tyrosine kinase inhibitor
2016
The Journal of Nuclear Medicine
Joseph Petrulli
Søren B. Hansen
Galith Abourbeh
Maqsood Yaqub
Daniel Holden
Joseph N. Contessa
Eyal Mishani
Adriaan A. Lammertsma
Evan D. Morris
Show All
Source
Cite
Save
Citations (0)
Mice Deficient in Ribosomal Protein S6 Phosphorylation Suffer from Muscle Weakness that Reflects a Growth Defect and Energy Deficit
2009
PLOS ONE
Igor Ruvinsky
Maximiliano Katz
Avigail Dreazen
Yuval Gielchinsky
Ann Saada
Nanette Freedman
Eyal Mishani
Gabriel Zimmerman
Judith Kasir
Oded Meyuhas
Show All
Source
Cite
Save
Citations (84)
1